ASAAP-plus: Clinical evaluation of AntimalarialS tri-therapy with AtovAquone-Proguanil for treatment of uncompli...
INSTITUT DE RECHERCHE CLINIQUE DU BENIN (IRCB)
participó en un
HORIZON EUROPE:
HORIZON-JU-GH-EDCTP3-2023-01
Susceptibility to Artemisinin-based combination therapies (ACTs) currently remains high among the African Plasmodium falciparum population,...
2024-03-11 - 2025-12-31 | Financiado
2024-03-11 - 2025-12-31 | Financiado
* No se disponen de datos de la empresa actual.